GSEP
MRK icon

Golden State Equity Partners’s Merck MRK Stock Holding History

Golden State Equity Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.5K Sell
300
-34,068
-99% -$3.99M 0.1% 119
2026
Q1 		$4.13M Buy
34,368
+9,907
+41% +$1.14M 0.31% 66
2025
Q4 		$2.57M Sell
24,461
-1,105
-4% -$104K 0.42% 44
2025
Q3 		$2.15M Sell
25,566
-1,402
-5% -$115K 0.36% 57
2025
Q2 		$2.13M Sell
26,968
-13,135
-33% -$1.04M 0.4% 54
2025
Q1 		$3.6M Buy
40,103
+121
+0.3% +$11.3K 0.71% 25
2024
Q4 		$3.98M Buy
39,982
+7,816
+24% +$806K 0.76% 20
2024
Q3 		$3.65M Buy
32,166
+3,829
+14% +$455K 0.57% 34
2024
Q2 		$3.51M Buy
+28,337
New +$3.65M 0.73% 21
2023
Q4 		$3.14M Sell
28,831
-68
-0.2% -$7.06K 0.76% 26
2023
Q3 		$2.98M Sell
28,899
-134
-0.5% -$14.4K 0.83% 25
2023
Q2 		$3.35M Buy
29,033
+6,538
+29% +$742K 0.94% 20
2023
Q1 		$2.39M Buy
+22,495
New +$2.43M 1.3% 17
2022
Q1 		$1.82M Sell
22,236
-7,660
-26% -$604K 0.92% 30
2021
Q4 		$2.29M Buy
29,896
+10,876
+57% +$866K 1.16% 27
2021
Q3 		$1.43M Sell
19,020
-1,334
-7% -$101K 0.58% 39
2021
Q2 		$1.58M Sell
20,354
-2,608
-11% -$194K 0.61% 36
2021
Q1 		$1.69M Buy
22,962
+3,169
+16% +$234K 0.96% 29
2020
Q4 		$1.54M Buy
+19,793
New +$1.51M 1.06% 25

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Golden State Equity Partners's MRK Position: Q2 2026 in Review

Golden State Equity Partners reduced its Merck (MRK) stake by 99% in Q2 2026, selling an estimated $3.99M and leaving 300 shares worth $38.5K. The position accounts for 0.1% of the portfolio, ranked #119.

Golden State Equity Partners first reported a position in MRK in Q4 2020 and has held it in 19 quarters since. The position peaked at $4.13M in Q1 2026. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Golden State Equity Partners held 300 shares of Merck worth $38.5K as of Q2 2026.
  • Golden State Equity Partners sold 34,068 Merck shares in Q2 2026, an estimated $3.99M.
  • Merck made up 0.1% of Golden State Equity Partners's portfolio in Q2 2026, its #119 holding.
  • Golden State Equity Partners first reported a position in Merck in Q4 2020 and has held it in 19 quarters since.
  • Golden State Equity Partners's Merck position peaked at $4.13M in Q1 2026.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.